By hiring several world class scientists to your team and having two locations in San Francisco and Geneva, Switzerland! Obviously, Amarantus is preparing themselves for something big that they know is coming. Dr. Lowe's NeuroAssets is also located in Geneva, and Wakefield is going to be working with Lowe on the Eltoprazine LID clinical trials. The PR mentioned Regulatory Agencies for LID in both the U.S. and Europe. Maybe our partner on Eltoprazine will be in Europe?
Yeah, Gerald keeps intimating big possibilities with statements he makes, peaking our curiosity, but never giving us enough details to know what to make of things! So we trade at .073 cents when everyone anticipated we'd be trading much higher by now. Gerald's credibility is on the line by playing a very high stakes game, lining up all the dominoes, as you mentioned, but remaining mysteriously quiet about how he'll start the chain reaction that moves us upward to .20 or .30 cents! He's upgraded our office space locations to two very high profile bio-med cities: San Francisco & Geneva, he's hired expensive world class people, he's raised expectations that we'll up list this year, and that we'll have a commercialization partner for LymPro that will be revenue producing by year end. He is acting as though we already were a "world class company." Now we just need the world class market cap to go along with it!